These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6211063)

  • 1. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
    Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
    Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
    Ohta M; Takeda A; Ninagawa T; Tomoda Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
    [No Abstract]   [Full Text] [Related]  

  • 4. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of receptors in the management of endometrial cancer.
    Richardson GS; MacLaughlin DT
    Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
    Ide P; Bonte J
    Br J Cancer; 1974 Aug; 30(2):175. PubMed ID: 4419502
    [No Abstract]   [Full Text] [Related]  

  • 10. Histological evaluation of in vitro responses of endometrial adenocarcinoma to progestins and their relation to progesterone receptor levels.
    Holinka CF; Deligdisch L; Gurpide E
    Cancer Res; 1984 Jan; 44(1):293-6. PubMed ID: 6690040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
    Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R
    Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M; Pickel H
    Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
    Rendina GM; Donadio C; Fabri M; Mazzoni P; Nazzicone P
    Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
    Ayoub J; Audet-Lapointe P; Méthot Y; Hanley J; Beaulieu R; Chemaly R; Cormier A; Déry JP; Drouin P; Gauthier P
    Gynecol Oncol; 1988 Oct; 31(2):327-37. PubMed ID: 2971597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
    Kauppila A; Vihko R
    Acta Obstet Gynecol Scand; 1981; 60(6):589-90. PubMed ID: 6461159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gestagen treatment of endometrial carcinoma].
    Seewald HJ; Böhm W
    Zentralbl Gynakol; 1974 Feb; 96(5):153-7. PubMed ID: 4133105
    [No Abstract]   [Full Text] [Related]  

  • 20. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
    Bonte J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.